Nifty 17196.7 (-1.18%)
Sensex 57696.46 (-1.31%)
Nifty Bank 36197.15 (-0.85%)
Nifty IT 35848.05 (-0.86%)
Nifty Financial Services 17779.5 (-1.13%)
Adani Ports 737.45 (-0.22%)
Asian Paints 3110.45 (-2.21%)
Axis Bank 673.00 (-0.46%)
B P C L 385.90 (1.86%)
Bajaj Auto 3287.85 (-1.22%)
Bajaj Finance 7069.25 (-1.55%)
Bajaj Finserv 17488.70 (-1.52%)
Bharti Airtel 718.35 (-1.94%)
Britannia Inds. 3553.75 (-0.69%)
Cipla 912.05 (-1.00%)
Coal India 159.75 (0.28%)
Divis Lab. 4757.05 (-0.42%)
Dr Reddys Labs 4596.50 (-1.42%)
Eicher Motors 2455.55 (0.16%)
Grasim Inds 1703.90 (-1.16%)
H D F C 2771.65 (-1.29%)
HCL Technologies 1171.40 (-1.12%)
HDFC Bank 1513.55 (-0.80%)
HDFC Life Insur. 690.95 (-2.03%)
Hero Motocorp 2462.45 (-0.41%)
Hind. Unilever 2343.65 (-1.66%)
Hindalco Inds. 424.65 (-1.72%)
I O C L 122.20 (1.28%)
ICICI Bank 716.30 (-0.84%)
IndusInd Bank 951.15 (0.59%)
Infosys 1735.55 (-0.73%)
ITC 221.65 (-1.69%)
JSW Steel 644.55 (-0.34%)
Kotak Mah. Bank 1914.20 (-2.55%)
Larsen & Toubro 1801.25 (0.67%)
M & M 836.95 (-1.48%)
Maruti Suzuki 7208.70 (-1.59%)
Nestle India 19321.35 (-0.93%)
NTPC 127.00 (-1.32%)
O N G C 145.90 (1.32%)
Power Grid Corpn 206.10 (-3.92%)
Reliance Industr 2408.25 (-3.00%)
SBI Life Insuran 1165.95 (-1.86%)
Shree Cement 25914.05 (-1.43%)
St Bk of India 473.15 (-0.81%)
Sun Pharma.Inds. 751.80 (-1.89%)
Tata Consumer 774.30 (0.14%)
Tata Motors 480.10 (0.21%)
Tata Steel 1118.00 (0.50%)
TCS 3640.45 (-0.07%)
Tech Mahindra 1593.30 (-2.23%)
Titan Company 2369.25 (-0.72%)
UltraTech Cem. 7332.45 (0.13%)
UPL 712.75 (2.08%)
Wipro 640.75 (-0.94%)

These stocks are likely to be in focus on October 21.

These stocks are likely to be in focus on October 21.
by 5paisa Research Team 20/10/2021

Benchmark indices ended in red for the second consecutive session on October 20 amid selling witnessed across the sectors.

At close, the Sensex was down 456.09 points or 0.74% at 61,259.96 level, and the Nifty lowered 152.20 points or 0.83% settling at 18,266.60 level. Bharti Airtel, SBI, IndusInd Bank and Bajaj Finance were the top Sensex gainers whereas Titan Company, HUL, NTPC and Larsen and Toubro were the top Sensex losers.

On Wednesday, about 877 shares have advanced, 2351 shares declined, and 115 shares are unchanged. All the sectoral indices settled in red and in the broader markets, BSE midcap and smallcap indices lost 2% each.

Watch out for these stocks in Thursday’s trading session:

Mindtree – The company has been selected as a strategic partner by Western Asset, one of the world’s leading active fixed-income investment managers, to help drive innovation and differentiated experiences for the company’s global investors. The initial partnership will be for the Western Asset team on their IT infrastructure and application portfolio, while also enabling several strategic business initiatives.

Jubilant FoodWorks – The company declared its results for Q2FY22 which revealed that the net profit rose 58% recording at Rs 121.52 crore versus Rs 76.9 crore reported in Q2FY21. Revenue zoomed 36.6% at Rs 1,101 crore as compared to Rs 805.5 crore on a YoY basis. Whereas on a YoY basis, earnings before interest, tax, depreciation and amortization (EBITDA) stood 33.2% higher at Rs 286 crore in comparison with Rs 214.6 crore.

52-week high stocks – Amid the downside experienced in the markets on Wednesday, the stocks of ICICI Bank, Infosys, SBI and Tech Mahindra in the Sensex pack outperformed the index and made fresh 52-week highs. These stocks are likely to be on the watchlist for Thursday's trading session.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Closing Bell: Market extends losses, Sensex falls by 456 points, Nifty slips below 18300.

Closing Bell: Market extends losses, Sensex falls by 456 points, Nifty slips below 18300.
by 5paisa Research Team 20/10/2021

Equity indices plunged into the red on October 21, 2021, in a highly volatile and profit-booking trading session.


Domestic equity benchmarks Sensex and Nifty50 gave up the initial gains in a volatile trading session on Wednesday. Losses witnessed in oil and gas, financial services, metals and consumer goods pulled the market lower. Broader markets were also volatile and slipped deep into the red. BSE Smallcap index closed at 28,878.73 recording losses of 2.31%.

At the closing bell on Wednesday, the Sensex closed down by 456.09 points or 0.74% at 61,259.96, and the Nifty ended lower by 152.20 points or 0.83% at 18,266.60. Today, 877 shares advanced, 2351 shares declined, and 115 shares were unchanged.

Among the top gainers today were, Bharti Airtel, SBI, Axis Bank, Bajaj Finance, Tech Mahindra and ICICI Bank. While the top losers of the day were Titan Company, HUL, BPCL and Bajaj Finserv.

All the sectoral indices ended in red, with BSE midcap and smallcap losing 2% each.

According to market experts, investors are booking profits at every peak, adding volatility to the market. They also view that investors were awaiting corporate views during September-quarter earnings as higher commodity costs and raw material expenses are expected to hurt margins for companies even as they post profit increases. The market has given us many instances in the recent past where it has been a very promising buy on dips strategy that works.

Consumer giant Hindustan Unilever went down by almost 2.5% to Rs 2,484 after it warned that margins could remain under pressure in the near term due to elevated commodity prices.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Peaks and valleys in the pharma industry-Dr.Reddy’s share rises

by 5paisa Research Team 20/10/2021

Dr. Reddy's Vascepa share gains resume
Dr. Reddy's gVascepa Rx was up 34% monthly and the market share reached 5.5%. Hikma's Rx was up by 2% and the market share touched 14%, during the last 4 months. Vascepa's share came down to 80%, the lowest till date, per the latest weekly data. Dr. Reddy increases Suboxone share: Dr. Reddy's market share in the Suboxone market had remained stable for over a year and it started to move up in July-2021.Dr. Reddy's market share reached 19.8%.

Lupin’s rise in Albuterol HFA market. 
Lupin gains 67bps in Albuterol HFA. Lupin's Albuterol HFA Rx was up 5% last month with a stable total market Rx. Lupin rose by 14.7% which is a 67bps increase. Cipla lost 25bps share. Cipla's market share loss is for the first time since the product was launched. This may indicate that the stock is nearing its peak. Lupin shoots down by 320bps in market share in Famotidine oral solution market; the market share loss was at the slowest since the competitors launched products in May. Lupin's market share stands at 74.8%. 

Semglee market share gains move up by 2%
Seamless (Biocon's Insulin Glargine) Rx was up by 2% and market share remained steady at 4%. 
Updates on other Biosimilars
Biocon's Pegfilgrastim Rx was up by 13% m/m and resulted in 93bps of market share gains however Trastuzumab Rx decreased by 18% and reduced by 185bps share. Alembic loses share in Olmesartan, gains in Valsartan Alembic's Olmesartan Rx was down 13% and reached a market share of 10.2% (down 151bps), while Valsaratan Rx was up 3% with a market share of 20.3% (+44bps). The albuterol market seems to be stabilizing. Sun's Absorica generic Rx was up 10% YoY. Sublocade Rx trend continues to move up. Dr. Reddy's Suboxone share moved up in recent weeks. Sublocade prescriptions have gradually moved up in the last few months. Alvogen lost some Suboxone market share to Dr. Reddy's in recent weeks. The latest weekly data shows Vascepa's market share at 80%.Dr. Reddy's gVascepa share gains 142bps share. Lupin continues to lose share in Famotidine but gradually. Alembic lost 151bps share in Olmesartan during last. Alembic saw a slight market share uptick in Valsartan. The Mesalamine 1.2gm market was quite stable. The Mesalamine 1.2gm market was stable. The dry-eye market was unchanged.Ilumya Rx was down by 3% m/m.Cipla's Cinacalcet Rx was steady vs the previous month. Solos prescriptions were up 6% m/m. Biocon's Semglee market share gains have stalled in the last few weeks. Biocon's Pegfilgrastim Rx up 13% m/m.Amgen lost Pegfilgrastim share to peers in the last month.Biocon Trastuzumab Rx down 18% m/m.Biocon-Viatris's Trastuzumab Rx share falls to 15.3% from 17.2%. Biocon-Viatris's market share (for August) by IQVIA sales is 5.9% in Trastuzumab. Lupin's Glumetza share is largely stable.
 

Peaks and valleys in the pharma industry-Dr.Reddy’s share rises
Dr. Reddy's Vascepa share gains resume
Dr. Reddy's gVascepa Rx was up 34% monthly and the market share reached 5.5%. Hikma's Rx was up by 2% and the market share touched 14%, during the last 4 months. Vascepa's share came down to 80%, the lowest till date, per the latest weekly data. Dr. Reddy increases Suboxone share: Dr. Reddy's market share in the Suboxone market had remained stable for over a year and it started to move up in July-2021.Dr. Reddy's market share reached 19.8%.

Lupin’s rise in Albuterol HFA market. 
Lupin gains 67bps in Albuterol HFA. Lupin's Albuterol HFA Rx was up 5% last month with a stable total market Rx. Lupin rose by 14.7% which is a 67bps increase. Cipla lost 25bps share. Cipla's market share loss is for the first time since the product was launched. This may indicate that the stock is nearing its peak. Lupin shoots down by 320bps in market share in Famotidine oral solution market; the market share loss was at the slowest since the competitors launched products in May. Lupin's market share stands at 74.8%. 

Semglee market share gains move up by 2%
Seamless (Biocon's Insulin Glargine) Rx was up by 2% and market share remained steady at 4%. 
Updates on other Biosimilars
Biocon's Pegfilgrastim Rx was up by 13% m/m and resulted in 93bps of market share gains however Trastuzumab Rx decreased by 18% and reduced by 185bps share. 
Alembic loses share in Olmesartan, gains in Valsartan 
Alembic's Olmesartan Rx was down 13% and reached a market share of 10.2% (down 151bps), while Valsaratan Rx was up 3% with a market share of 20.3% (+44bps). 
The albuterol market seems to be stabilizing. Sun's Absorica generic Rx was up 10% YoY. Sublocade Rx trend continues to move up. Dr. Reddy's Suboxone share moved up in recent weeks. Sublocade prescriptions have gradually moved up in the last few months. Alvogen lost some Suboxone market share to Dr. Reddy's in recent weeks. The latest weekly data shows Vascepa's market share at 80%.Dr. Reddy's gVascepa share gains 142bps share. Lupin continues to lose share in Famotidine but gradually. Alembic lost 151bps share in Olmesartan during last. Alembic saw a slight market share uptick in Valsartan. The Mesalamine 1.2gm market was quite stable. The Mesalamine 1.2gm market was stable. The dry-eye market was unchanged.Ilumya Rx was down by 3% m/m.Cipla's Cinacalcet Rx was steady vs the previous month. Solos prescriptions were up 6% m/m. Biocon's Semglee market share gains have stalled in the last few weeks. Biocon's Pegfilgrastim Rx up 13% m/m.Amgen lost Pegfilgrastim share to peers in the last month.Biocon Trastuzumab Rx down 18% m/m.Biocon-Viatris's Trastuzumab Rx share falls to 15.3% from 17.2%. Biocon-Viatris's market share (for August) by IQVIA sales is 5.9% in Trastuzumab. Lupin's Glumetza share is largely stable.
 

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Jindal Stainless (Hisar) commissions Phase I of brown-field expansion at speciality products division.

Jindal Stainless (Hisar) commissions Phase I of brown-field expansion at speciality products division.
by 5paisa Research Team 20/10/2021

This capacity expansion takes the total precision strip production capacity to 48,000 TPA from the existing 22,000 TPA.

Jindal Stainless (Hisar) has announced that it has commissioned 26,000 tons per annum (TPA) capacity Precision Strip Mill as part of the first phase of its latest brown-field expansion plan at its Specialty Products Division (SPD).

The capacity expansion of precision strips will further strengthen the company’s presence in segments like auto, process industry, and oil and petrochemical. It will also be augmenting supplies to aerospace and electric vehicles. This capacity expansion takes the total precision strip production capacity to 48,000 TPA from the existing 22,000 TPA. 

The total capital expenditure for the brownfield expansion is estimated at Rs 450 crore over the next two years. As part of the expansion, the company plans to increase its total precision strip capacity to 60,000 tons per annum by the end of Q2FY23 with an estimated capital expenditure of Rs 250 crore.

The capacity expansion at SPD is part of the company’s plan to leverage its leadership position in speciality and value-added products. After this expansion, the operational capability will expand and products up to 650 mm width would be manufactured. This expansion will further help the company consolidate its leadership position in the international markets as well.

Managing Director of Jindal Stainless (Hisar), Abhyuday Jindal stated in a filing with the exchange, “The latest capacity addition to JSHL’s Specialty Products Division portfolio will strengthen our product mix in the value-added segment and double our share in the global production to 8%. The capacity enhancement is expected to boost JSHL’s revenues by 8-10%.” 

Jindal Stainless (Hisar) is an integrated stainless-steel manufacturer with facilities starting from melting, casting, and hot rolling to cold rolling and other value additions. It has a melting capacity of 800,000 TPA. The company’s Specialty Product Division (SPD) caters to the high-end precision and speciality stainless steel requirements of reputed Indian and international customers. This division serves the niche requirements in thinner sections for specific applications in various stainless-steel grades.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

BSE 500: These shares gained with price volume breakout when Sensex tumbled.

BSE 500: These shares gained with price volume breakout when Sensex tumbled.
by 5paisa Research Team 20/10/2021

The stocks rising with increasing volumes can be considered to reflect a continuation of the trend.

The frontline indices tumbled on Wednesday with BSE Sensex losing 456 points and Nifty 50 slipping by 152.15 points.

BSE 500 index slipped by more than 1% on Wednesday on a closing basis. Shriram City Union Finance was the top BSE 500 index gainer, up by nearly 8%. Idea helped push the BSE Telecom index by gaining more than 7%.

The Nifty continued to trade with weakness on Wednesday, witnessing a follow-through decline. However, Nifty opened in the green. There was some minor recovery in the last few minutes of the trading session. A long bearish candle was formed in Nifty on the daily chart. This indicates a reversal in the market.

IRCTC and Deepak Nitrate featured amongst the top BSE 500 losers. IRCTC was down by more than 17% while Deepak Nitrate slipped by more than 11% on Wednesday on a closing basis. Other BSE 500 top losers on Wednesday remained Cera Sanitaryware, Navin Fluorine, Dixon Technologies, Jubilant Foods and Aarti industries.

While the overall markets remained weak there were few BSE 500 stocks that managed to outperform. Few of the BSE 500 components gained with rising volumes on a closing basis.

Here is the list of top 10 BSE 500 gainers on Wednesday that saw a price volume breakout:

  

Sr No   

Stocks   

LTP   

Price gain (%)   

Volume change (times)   

1  

Mahindra Lifespace Developers   

289.95  

7.37  

3.03  

2  

IDEA   

10.7  

7  

2.13  

3  

Shriram City Union Finance   

2368  

7.78  

2.03  

4  

CG Power   

136.85  

4.99  

1.83  

5  

Sterlite Technology   

284.7  

4.1  

2.2  

6  

Bharti Airtel   

708.1  

3.96  

2.59  

7  

Equitas Holdings   

127.4  

3.49  

1.58  

8  

Balmar Lawrie   

133.5  

3.05  

6.65  

9  

Vinati Organics   

2061.15  

2.79  

1.79  

10  

SBI   

501.2  

2.66  

1.67  

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Top 10 Small-cap losers.

Top 10 Small-cap losers.
by 5paisa Research Team 20/10/2021

In the last two days, Nifty Small-cap 100 has seen a sharp cut. It is down by almost 6% from its recent high.

The small-cap stocks are one of the best performers in all the trailing periods in the last eighteen months. In March 2020, the market slipped down very sharply due to coronavirus concerns and subsequent lockdown. Small-cap stocks that were not doing well were the ones most affected by the downfall of the market.

Investors who saw the courage and invested or entered during downfall were the ones who are earning maximum profits as small-cap stocks are on average giving return in triple-digit.

Nevertheless, in the last two days, Nifty Small-cap 100 has seen a sharp cut. It closed at 11,202.10 in today’s trade and is down by almost 6% from its recent high. From March 2020 to October 2021 Nifty Smallcap 100 has increased by almost 235%. In the recent fall, the stocks that are supporting the index up are IRB Infra, Sterlite Techno, Indian Bank, Tanla Platforms and CDSL. IRB Infra and Sterlite Techno are up by 3.89% at Rs 212.2 and 3.42% at Rs 282.82 respectively, which closed in the green mark in today’s trade. Stocks pulling down the Nifty Small-cap Index are listed below in the table.

The index opened 15.5 points higher than the previous close, the day high on 20th October 2021 is 11,496.65 whereas, day's low is 11,122.35.

List of top 10 stocks of Nifty Smallcap 100 which were hit severely in two-day fall and closed red in today’s trade: 

Company Name  

High   

Low  

Last price  

Previous Close  

Change  

Change%  

Rallis India  

295  

279.90  

282.45  

304.10  

-21.65  

-7.12%  

Balrampur Chini Mills  

370.25  

330.05  

344.30  

369.90  

-25.75  

-6.96%  

Bajaj Electricals   

1279.75  

1150.00  

1188.15  

1273.75  

-85.6  

-6.72%  

Chambal Fertilisers and Chemicals  

369.00  

334.00  

343.10  

367.60  

-24.5  

-6.66%  

IEX  

844.00  

756.55  

789.45  

845.35  

-55.9  

-6.61%  

PNB Housing Finance  

570.00  

547.65  

547.65  

576.45  

-28.8  

-5.00%  

Amber Enterprises India  

3635.75  

3335.00  

3428.20  

3602.20  

-174  

-4.83%  

Carborundum Universal  

  

876.00  

825.00  

835.70  

876.15  

-40.45  

-4.62%  

Sonata Software   

1024.90  

899.00  

917.65  

961.20  

-43.55  

-4.53%  

KEI Industries   

993.00  

922.45  

985.80  

942.55  

-43.25  

-4.39  

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order